The Lithuanian Competition Council closes an investigation and accepts remedies on vertical restraints implemented by several pharmaceutical undertakings and gives a recommendation to the Ministry of Health on ways to promote parallel imports of pharmaceuticals

On 21 July 2011 the Competition Council terminated the investigation on compliance of actions of several pharmaceutical undertakings with Article 5 of the Law on Competition and Article 101 TFEU by accepting commitments (Article 30(2) point 2 [now Article 28(3) point 2] of the Law on Competition). The investigation was started on the basis of potential competition law concerns regarding vertical agreements which were entered into by five pharmaceutical producers (which acted in Lithuania through their subsidiaries) and three pharmaceutical wholesale distributors. Some vertical agreements of undertakings entailed clauses by which a distributor was authorized by a producer to participate in a public tender for a procurement of pharmaceuticals by hospitals and other budgetary

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Max Planck Institute for Innovation and Competition (Munchen)

Quotation

Gintarė Surblytė, The Lithuanian Competition Council closes an investigation and accepts remedies on vertical restraints implemented by several pharmaceutical undertakings and gives a recommendation to the Ministry of Health on ways to promote parallel imports of pharmaceuticals, 13 December 2013, e-Competitions Bulletin December 2013, Art. N° 65337

Visites 795

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues